Thorat, M. A. (2016). Individualised benefit–harm balance of aspirin as primary prevention measure – a good proof-of-concept, but could have been better…. BMC Med.
Styl cytowania ChicagoThorat, Mangesh A. "Individualised Benefit–harm Balance of Aspirin As Primary Prevention Measure – a Good Proof-of-concept, but Could Have Been Better…." BMC Med 2016.
Styl cytowania MLAThorat, Mangesh A. "Individualised Benefit–harm Balance of Aspirin As Primary Prevention Measure – a Good Proof-of-concept, but Could Have Been Better…." BMC Med 2016.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..